Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, monohydrate, (5α,6α)-

Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, monohydrate, (5α,6α)-

Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, monohydrate, (5α,6α)- structure

Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, monohydrate, (5α,6α)- 

structure
  • CAS No:

    6059-47-8

  • Formula:

    C18H21NO3.H2O

  • Chemical Name:

    Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, monohydrate, (5α,6α)-

  • Synonyms:

    Morphinan-6-ol,7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-,monohydrate,(5α,6α)-;Morphinan-6α-ol,7,8-didehydro-4,5α-epoxy-3-methoxy-17-methyl-,monohydrate;Codeine monohydrate;7445-78-5

  • Categories:

    Analytical Chemistry  >  Standard

Description

Codeine is a naturally occurring phenanthrene alkaloid and opioid agonist with analgesic, antidiarrheal and antitussive activities. Codeine mimics the actions of endogenous opioids by binding to the opioid receptors at many sites within the central nervous system (CNS). Stimulation of mu-subtype opioid receptors results in a decrease in the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline; in addition, the codeine metabolite morphine induces opening of G-protein-coupled inwardly rectifying potassium (GIRK) channels and blocks the opening of N-type voltage-gated calcium channels, resulting in hyperpolarization and reduced neuronal excitability. Stimulation of gut mu-subtype opioid receptors results in a reduction in intestinal motility and delayed intestinal transit times. Antitussive activity is mediated through codeine's action on the cough center in the medulla.

Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, monohydrate, (5α,6α)- Basic Attributes

317.37952

317.163

200-969-1

Q830PW7520

DTXSID20209391

C383

Characteristics

42.9

1.295 g/cm3

80 °C

8.26g/L(cold water)

2-8°C

Safety Information

3

22

36/37

Xn

P201, P202, P260, P261, P263, P264, P270, P271, P272, P280, P281, P285, P301+P310, P301+P312, P302+P352, P304+P312, P304+P340, P304+P341, P308+P313, P312, P321, P330, P333+P313, P342+P311, P363, P405, P501

H301

|Danger|H301 (10.53%): Toxic if swallowed [Danger Acute toxicity, oral]|P201, P202, P260, P261, P263, P264, P270, P271, P272, P280, P281, P285, P301+P310, P301+P312, P302+P352, P304+P312, P304+P340, P304+P341, P308+P313, P312, P321, P330, P333+P313, P342+P311, P363, P405, and P501|Aggregated GHS information provided by 19 companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, monohydrate, (5α,6α)- Use and Manufacturing

Antitussive; analgesic (narcotic).

Computed Properties

Molecular Weight:317.4
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:1
Exact Mass:317.16270821
Monoisotopic Mass:317.16270821
Topological Polar Surface Area:42.9
Heavy Atom Count:23
Complexity:509
Defined Atom Stereocenter Count:5
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.